A traditional Chinese medicine composition for treating post-stroke depression

Abstract

The invention discloses a traditional Chinese medicine composition for treating post-stroke depression, which comprises the following raw materials in parts by weight: 15-30 parts of Bupleuri, 10-20 parts of Rhizoma Cyperi, 10-20 parts of Angelica, 10-20 parts of Rehmannia, 10 parts of peach kernel ‑20 parts, 10‑15 parts of safflower, 10‑20 parts of Citrus aurantii, 10‑20 parts of tangerine peel, 10‑20 parts of red peony, 10‑20 parts of Atractylodes macrocephala, 10‑15 parts of licorice, 10‑20 parts of bellflower, beef Knee 6‑20 parts, Chuanxiong 10‑20 parts, leeches 4‑6 parts, Panax notoginseng 10‑15 parts, Poria cocos 15‑20 parts, Shichangpu 15‑20 parts, Dannanxing 12‑20 parts, Hypericum perforatum 3‑ 6 parts, Acanthopanax 12‑20 parts, Coptidis 3‑6 parts, all medicines are used in combination to soothe the liver and relieve depression, regulate qi and resolve phlegm, promote blood circulation and resolve stagnation. The combined use of the traditional Chinese medicine composition and antidepressants has remarkable curative effect on treating post-stroke depression, has reliable effects, has no side effects, and shortens the onset time of antidepressants.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating post-stroke depression, belonging to the field of traditional Chinese medicine preparations. Background technique [0002] Common psychological and mental diseases after stroke include post-stroke depression, which not only affects the quality of life of patients, but also affects neurological recovery and increases mortality and suicide rates. Selective serotonin reuptake inhibitors (SSRIs) and other newer antidepressants are currently the main drugs for the treatment of post-stroke depression. Although these drugs can effectively relieve depression and accompanying anxiety, tension, and physical symptoms, about 20-40% of physical symptoms such as gastrointestinal side effects are still not relieved, resulting in a decrease in patient compliance or interruption of treatment. At the same time, such western medicines have delayed onset of effect and increased risks of cere...

AI Technical Summary

Problems solved by technology

Although these drugs can effectively relieve the depressed mood and accompanying anxiety, tension and physical symptoms, about 20-40% of the physical symptoms such as gastrointestinal side effects are not relieved, resulting in a decline in patient compliance or interruption of treatment

At the same time, this type of western medicine has delayed onset of effect, increased risks of cerebral hemorrhage, stroke, myocardial infarction, etc., which further limits the clinical efficacy of post-stroke depression.

Images